Literature DB >> 17603635

Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor.

Xinlei Chen1, Jayaprakash Aravindakshan, Yinzhi Yang, M Ram Sairam.   

Abstract

Little is known about the behavior of the ovarian surface epithelium (OSE), which plays a central role in ovarian cancer etiology. It has been suggested that incessant ovulation causes OSE changes leading to transformation and that high gonadotropin levels during postmenopause activate OSE receptors, inducing proliferation. We examined the chronology of OSE changes, including tumor appearance, in a mouse model where ovulation never occurs due to deletion of follitropin receptor. Changes in epithelial cells were marked by pan-cytokeratin (CK) staining. Histologic changes and CK staining in the OSE increased from postnatal day 2. CK staining was observed inside the ovary by 24 days and increased thereafter in tumor-bearing animals. Ovaries from a third of aged (1 year) mutant mice showed CK deep inside, indicating cell migration. These tumors resembled serous papillary adenoma of human ovaries. Weak expression of GATA-4 and elevation of PCNA, cyclooxygenase-1, cyclooxygenase-2, and platelet-derived growth factor receptors alpha and beta in mutants indicated differences in cell proliferation, differentiation, and inflammation. Thus, we report that OSE changes occur long before epithelial tumors appear in FORKO mice. Our results suggest that neither incessant ovulation nor follicle-stimulating hormone receptor presence in the OSE is required for inducing ovarian tumors; thus, other mechanisms must contribute to ovarian tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603635      PMCID: PMC1899255          DOI: 10.1593/neo.07238

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  45 in total

Review 1.  The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

Authors:  L Dubeau
Journal:  Gynecol Oncol       Date:  1999-03       Impact factor: 5.482

Review 2.  The biology of ovarian cancer.

Authors:  N Auersperg; M I Edelson; S C Mok; S W Johnson; T C Hamilton
Journal:  Semin Oncol       Date:  1998-06       Impact factor: 4.929

3.  Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium.

Authors:  B R Davies; D S Finnigan; S K Smith; B A Ponder
Journal:  Gynecol Endocrinol       Date:  1999-04       Impact factor: 2.260

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer?

Authors:  Olivia L Tan; Peter R Hurst; Jean S Fleming
Journal:  J Pathol       Date:  2005-03       Impact factor: 7.996

6.  Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture.

Authors:  Keith A Crist; Zhongqiu Zhang; Ming You; William T Gunning; Phillip B Conran; Vernon E Steele; Ronald A Lubet
Journal:  Carcinogenesis       Date:  2005-02-03       Impact factor: 4.944

Review 7.  Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.

Authors:  H A Risch
Journal:  J Natl Cancer Inst       Date:  1998-12-02       Impact factor: 13.506

8.  Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.

Authors:  K M Lau; S C Mok; S M Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.

Authors:  A Dierich; M R Sairam; L Monaco; G M Fimia; A Gansmuller; M LeMeur; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

Authors:  M Tsujii; S Kawano; S Tsuji; H Sawaoka; M Hori; R N DuBois
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  8 in total

1.  Sex Differences in Embryonic Gonad Transcriptomes and Benzo[a]pyrene Metabolite Levels After Transplacental Exposure.

Authors:  Jinhwan Lim; Aramandla Ramesh; Toshi Shioda; Kathleen Leon Parada; Ulrike Luderer
Journal:  Endocrinology       Date:  2022-01-01       Impact factor: 4.736

2.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.

Authors:  Irma Virant-Klun; Martin Stimpfel
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

Review 5.  The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.

Authors:  Chanitra Thuwajit; Alessandra Ferraresi; Rossella Titone; Peti Thuwajit; Ciro Isidoro
Journal:  Med Res Rev       Date:  2017-09-19       Impact factor: 12.944

Review 6.  Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3.

Authors:  Deepa Bhartiya; Hiren Patel; Ankita Kaushik; Pushpa Singh; Diksha Sharma
Journal:  J Ovarian Res       Date:  2021-10-30       Impact factor: 4.234

Review 7.  Very small embryonic-like stem cells: implications in reproductive biology.

Authors:  Deepa Bhartiya; Sreepoorna Unni; Seema Parte; Sandhya Anand
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

Review 8.  The Power of Phytochemicals Combination in Cancer Chemoprevention.

Authors:  Balsam Rizeq; Ishita Gupta; Josephine Ilesanmi; Mohammed AlSafran; Md Mizanur Rahman; Allal Ouhtit
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.